XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information
 9 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Segment Information
(17) Segment Information

The Company’s operations are comprised of two reportable segments: Healthcare Solutions and Industrial Solutions. Effective as of January 1, 2023, and for periods subsequent thereto, Adjusted EBITDA reflects the measure of profitability used by the Company’s chief operating decision maker (“CODM”) to evaluate the performance of the Company’s reportable segments. In addition, as of January 1, 2023, the Company's methodology for allocating certain costs between its segments was revised to more closely reflect changes in the Company's business and estimates of the usage of shared resources by the Company's segments. Prior year amounts have been reclassified to conform with current year presentation in connection with the changes referenced above. The following tables set forth our operating results by segment for the three and nine months ended September 30, 2023 and 2022:

RevenueAdjusted EBITDA
Three Months Ended September 30,Three Months Ended September 30,
(in thousands)2023202220232022
Healthcare Solutions$52,429 $64,203 $13,869 $13,787 
Industrial Solutions71,362 68,050 7,662 7,180 
Total Reportable segments123,791 132,253 21,531 20,967 
Corporate and Other(1)
— — (16,805)(21,288)
Total Company$123,791 $132,253 $4,726 $(321)
RevenueAdjusted EBITDA
Nine Months Ended September 30,Nine Months Ended September 30,
(in thousands)2023202220232022
Healthcare Solutions$162,028 $200,294 $30,328 $45,705 
Industrial Solutions211,193 205,005 16,828 16,473 
Total Reportable segments373,221 405,299 47,156 62,178 
Corporate and Other(1)
— — (59,422)(63,155)
Total Company$373,221 $405,299 $(12,266)$(977)

(1) Corporate and Other is not an operating segment, but reflects expenses not directly attributable to and, accordingly, not allocated to our reportable segments. These expenses relate to corporate functions such as human resources, finance, and legal and include expenses such as salaries, benefits, and other related costs. Similar to the Company's operating segments, Corporate results are reported to and reviewed by the Company’s CODM on the basis of Adjusted EBITDA.
The following table provides a reconciliation of the Company’s reported net loss to the total of our reportable segment Adjusted EBITDA and Corporate and Other Adjusted EBITDA for the three and nine months ended September 30, 2023 and 2022:
Three Months EndedNine Months Ended
(in thousands)September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Net loss attributable to 3D Systems Corporation$(11,704)$(37,398)$(70,020)$(97,158)
Interest (income) expense, net(4,909)(2,029)(13,118)(4,019)
Provision (benefit) for income taxes174 338 404 2,911 
Depreciation expense5,084 5,142 15,690 15,992 
Amortization expense3,179 4,293 9,676 10,273 
Stock-based compensation expense(3,142)11,44715,14031,508
Acquisition and divestiture-related expense(4,055)2,7281349,382
Legal expenses
2,1459,7074,88020,467
Restructuring expense1,50467 6,712 376 
Redeemable non-controlling interest(57)(147)(149)(184)
Loss on equity method investment605— 747— 
Asset impairment charges
13,5952,90914,2112,885
Other non-operating (income) expense2,3072,6223,4276,590
Adjusted EBITDA$4,726 $(321)$(12,266)$(977)